Company / Working Capital per Share
Fulcrum Therapeutics, Inc. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5436.54
FY2025
5-year range
$3727.35 / $5848.22
FY2021-FY2025
Trend
+41.1%
vs FY2024
Sector context
#3 of 210
Health Care
What the data says
Among 210 Health Care companies, Fulcrum Therapeutics, Inc. is in the top 1% for working capital per share. Working Capital per Share has fluctuated over the past 8 years, ranging from $3659.58 in FY2020 to $55581.54 in FY2018.
Based on SEC 10-K filings.
5436.54 in FY2025 with a 5-year CAGR of +8.2%. Ranks 3rd among 210 companies in Health Care.
Improved from $3727.35 to $5436.54 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +8.6%
- 5-Year CAGR
- +8.2%
- 10-Year CAGR
- -
Sector benchmark
+3601.8% above sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 41.1% year-over-year.
- Ranks #3 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2018.
- Lowest working capital per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.44 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5436.54 | +41.1% |
| FY2024 | $3853.88 | +3.4% |
| FY2023 | $3727.35 | -12.1% |
| FY2022 | $4240.71 | -27.5% |
| FY2021 | $5848.22 | +59.8% |
| FY2020 | $3659.58 | -54.0% |
| FY2019 | $7961.52 | -85.7% |
| FY2018 | $55581.54 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026